ALGONQUIN PWR & UTILITY - AQNCN 8.86372 07/01/2079 (AQNB) Fundamental Analysis & Valuation

NYSE:AQNB • US0158578080

Current stock price

26.045 USD
-0.13 (-0.52%)
Last:

This AQNB fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. AQNB Profitability Analysis

1.1 Basic Checks

  • In the past year AQNB was profitable.
  • AQNB had a positive operating cash flow in the past year.
  • In multiple years AQNB reported negative net income over the last 5 years.
  • Each year in the past 5 years AQNB had a positive operating cash flow.
AQNB Yearly Net Income VS EBIT VS OCF VS FCFAQNB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M -500M -1B

1.2 Ratios

  • AQNB's Return On Assets of 1.20% is on the low side compared to the rest of the industry. AQNB is outperformed by 92.31% of its industry peers.
  • With a Return On Equity value of 3.67%, AQNB is not doing good in the industry: 96.15% of the companies in the same industry are doing better.
  • AQNB has a worse Return On Invested Capital (3.19%) than 88.46% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for AQNB is in line with the industry average of 3.75%.
  • The 3 year average ROIC (2.59%) for AQNB is below the current ROIC(3.19%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 1.2%
ROE 3.67%
ROIC 3.19%
ROA(3y)-2.3%
ROA(5y)-1.32%
ROE(3y)-8.49%
ROE(5y)-5.07%
ROIC(3y)2.59%
ROIC(5y)2.46%
AQNB Yearly ROA, ROE, ROICAQNB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 -20

1.3 Margins

  • The Profit Margin of AQNB (7.00%) is worse than 92.31% of its industry peers.
  • AQNB's Profit Margin has declined in the last couple of years.
  • AQNB has a Operating Margin of 21.49%. This is comparable to the rest of the industry: AQNB outperforms 53.85% of its industry peers.
  • In the last couple of years the Operating Margin of AQNB has remained more or less at the same level.
  • With a decent Gross Margin value of 73.71%, AQNB is doing good in the industry, outperforming 73.08% of the companies in the same industry.
  • AQNB's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 21.49%
PM (TTM) 7%
GM 73.71%
OM growth 3Y5.14%
OM growth 5Y-1.15%
PM growth 3YN/A
PM growth 5Y-31.43%
GM growth 3Y1.65%
GM growth 5Y-0.89%
AQNB Yearly Profit, Operating, Gross MarginsAQNB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 -40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. AQNB Health Analysis

2.1 Basic Checks

  • AQNB has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • AQNB has about the same amout of shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, AQNB has more shares outstanding
  • The debt/assets ratio for AQNB is higher compared to a year ago.
AQNB Yearly Shares OutstandingAQNB Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M
AQNB Yearly Total Debt VS Total AssetsAQNB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B

2.2 Solvency

  • Based on the Altman-Z score of 1.27, we must say that AQNB is in the distress zone and has some risk of bankruptcy.
  • The Altman-Z score of AQNB (1.27) is better than 92.31% of its industry peers.
  • A Debt/Equity ratio of 1.33 is on the high side and indicates that AQNB has dependencies on debt financing.
  • AQNB has a better Debt to Equity ratio (1.33) than 69.23% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.33
Debt/FCF N/A
Altman-Z 1.27
ROIC/WACC0.46
WACC6.88%
AQNB Yearly LT Debt VS Equity VS FCFAQNB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B 4B 6B

2.3 Liquidity

  • A Current Ratio of 1.00 indicates that AQNB should not have too much problems paying its short term obligations.
  • With an excellent Current ratio value of 1.00, AQNB belongs to the best of the industry, outperforming 80.77% of the companies in the same industry.
  • AQNB has a Quick Ratio of 1.00. This is a bad value and indicates that AQNB is not financially healthy enough and could expect problems in meeting its short term obligations.
  • AQNB has a better Quick ratio (0.85) than 76.92% of its industry peers.
Industry RankSector Rank
Current Ratio 1
Quick Ratio 0.85
AQNB Yearly Current Assets VS Current LiabilitesAQNB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. AQNB Growth Analysis

3.1 Past

  • The earnings per share for AQNB have decreased strongly by -10.81% in the last year.
  • AQNB shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -12.41% yearly.
  • AQNB shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -20.38%.
  • The Revenue has been growing slightly by 7.73% on average over the past years.
EPS 1Y (TTM)-10.81%
EPS 3Y-22.17%
EPS 5Y-12.41%
EPS Q2Q%0%
Revenue 1Y (TTM)-20.38%
Revenue growth 3Y-4.17%
Revenue growth 5Y7.73%
Sales Q2Q%7.85%

3.2 Future

  • AQNB is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 10.85% yearly.
  • The Revenue is expected to grow by 6.69% on average over the next years.
EPS Next Y10.62%
EPS Next 2Y12.22%
EPS Next 3Y10.85%
EPS Next 5YN/A
Revenue Next Year5.57%
Revenue Next 2Y5.41%
Revenue Next 3Y6.69%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
AQNB Yearly Revenue VS EstimatesAQNB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B 2B 2.5B
AQNB Yearly EPS VS EstimatesAQNB Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.2 0.4 0.6

More info and screens

Find the best growth stocksShow best growing peers

0

4. AQNB Valuation Analysis

4.1 Price/Earnings Ratio

  • AQNB is valuated quite expensively with a Price/Earnings ratio of 78.92.
  • Based on the Price/Earnings ratio, AQNB is valued more expensive than 96.15% of the companies in the same industry.
  • The average S&P500 Price/Earnings ratio is at 27.18. AQNB is valued rather expensively when compared to this.
  • AQNB is valuated quite expensively with a Price/Forward Earnings ratio of 71.35.
  • 96.15% of the companies in the same industry are cheaper than AQNB, based on the Price/Forward Earnings ratio.
  • The average S&P500 Price/Forward Earnings ratio is at 37.96. AQNB is valued rather expensively when compared to this.
Industry RankSector Rank
PE 78.92
Fwd PE 71.35
AQNB Price Earnings VS Forward Price EarningsAQNB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, AQNB is valued more expensive than 96.15% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 28.82
AQNB Per share dataAQNB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates AQNB does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)7.43
PEG (5Y)N/A
EPS Next 2Y12.22%
EPS Next 3Y10.85%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. AQNB Dividend Analysis

5.1 Amount

  • AQNB has a Yearly Dividend Yield of 4.16%, which is a nice return.
  • AQNB's Dividend Yield is rather good when compared to the industry average which is at 3.29. AQNB pays more dividend than 92.31% of the companies in the same industry.
  • AQNB's Dividend Yield is rather good when compared to the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 4.16%

5.2 History

  • The dividend of AQNB decreases each year by -10.03%.
  • AQNB has been paying a dividend for over 5 years, so it has already some track record.
  • As AQNB did not decrease their dividend in the past 5 years, we can say the dividend looks stable.
Dividend Growth(5Y)-10.03%
Div Incr Years2
Div Non Decr Years5
AQNB Yearly Dividends per shareAQNB Yearly Dividends per shareYearly Dividends per share 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2

5.3 Sustainability

  • 124.37% of the earnings are spent on dividend by AQNB. This is not a sustainable payout ratio.
DP124.37%
EPS Next 2Y12.22%
EPS Next 3Y10.85%
AQNB Yearly Income VS Free CF VS DividendAQNB Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M -500M -1B
AQNB Dividend Payout.AQNB Dividend Payout, showing the Payout Ratio.AQNB Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

AQNB Fundamentals: All Metrics, Ratios and Statistics

26.045

-0.13 (-0.52%)

Chartmill FA Rating
GICS SectorUtilities
GICS IndustryGroupUtilities
GICS IndustryMulti-Utilities
Earnings (Last)03-06
Earnings (Next)05-08
Inst Owners74.05%
Inst Owner ChangeN/A
Ins Owners0.05%
Ins Owner ChangeN/A
Market Cap20.01B
Revenue(TTM)2.43B
Net Income(TTM)170.30M
Analysts71.67
Price Target20.24 (-22.29%)
Short Float %0%
Short Ratio0.37
Dividend
Industry RankSector Rank
Dividend Yield 4.16%
Yearly Dividend0.28
Dividend Growth(5Y)-10.03%
DP124.37%
Div Incr Years2
Div Non Decr Years5
Ex-Date06-15
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)34.87%
Min EPS beat(2)34.13%
Max EPS beat(2)35.61%
EPS beat(4)3
Avg EPS beat(4)27.8%
Min EPS beat(4)-0.69%
Max EPS beat(4)42.17%
EPS beat(8)4
Avg EPS beat(8)9.08%
EPS beat(12)5
Avg EPS beat(12)3.81%
EPS beat(16)7
Avg EPS beat(16)1.75%
Revenue beat(2)1
Avg Revenue beat(2)2.8%
Min Revenue beat(2)-1.85%
Max Revenue beat(2)7.44%
Revenue beat(4)3
Avg Revenue beat(4)2.93%
Min Revenue beat(4)-1.85%
Max Revenue beat(4)7.44%
Revenue beat(8)3
Avg Revenue beat(8)-0.96%
Revenue beat(12)6
Avg Revenue beat(12)-0.42%
Revenue beat(16)9
Avg Revenue beat(16)0.56%
PT rev (1m)5.57%
PT rev (3m)-3.25%
EPS NQ rev (1m)0.28%
EPS NQ rev (3m)N/A
EPS NY rev (1m)-0.3%
EPS NY rev (3m)-0.39%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)1.67%
Revenue NY rev (3m)1.23%
Valuation
Industry RankSector Rank
PE 78.92
Fwd PE 71.35
P/S 8.22
P/FCF N/A
P/OCF 33.71
P/B 4.31
P/tB 6.15
EV/EBITDA 28.82
EPS(TTM)0.33
EY1.27%
EPS(NY)0.37
Fwd EY1.4%
FCF(TTM)-0.23
FCFYN/A
OCF(TTM)0.77
OCFY2.97%
SpS3.17
BVpS6.04
TBVpS4.23
PEG (NY)7.43
PEG (5Y)N/A
Graham Number6.7
Profitability
Industry RankSector Rank
ROA 1.2%
ROE 3.67%
ROCE 4.04%
ROIC 3.19%
ROICexc 3.2%
ROICexgc 3.59%
OM 21.49%
PM (TTM) 7%
GM 73.71%
FCFM N/A
ROA(3y)-2.3%
ROA(5y)-1.32%
ROE(3y)-8.49%
ROE(5y)-5.07%
ROIC(3y)2.59%
ROIC(5y)2.46%
ROICexc(3y)2.6%
ROICexc(5y)2.47%
ROICexgc(3y)2.87%
ROICexgc(5y)2.72%
ROCE(3y)3.28%
ROCE(5y)3.12%
ROICexgc growth 3Y9.1%
ROICexgc growth 5Y5.22%
ROICexc growth 3Y8.32%
ROICexc growth 5Y5.24%
OM growth 3Y5.14%
OM growth 5Y-1.15%
PM growth 3YN/A
PM growth 5Y-31.43%
GM growth 3Y1.65%
GM growth 5Y-0.89%
F-Score6
Asset Turnover0.17
Health
Industry RankSector Rank
Debt/Equity 1.33
Debt/FCF N/A
Debt/EBITDA 6.68
Cap/Depr 192.83%
Cap/Sales 31.72%
Interest Coverage 1.68
Cash Conversion 64.28%
Profit Quality N/A
Current Ratio 1
Quick Ratio 0.85
Altman-Z 1.27
F-Score6
WACC6.88%
ROIC/WACC0.46
Cap/Depr(3y)198.53%
Cap/Depr(5y)233.69%
Cap/Sales(3y)37.34%
Cap/Sales(5y)42.05%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-10.81%
EPS 3Y-22.17%
EPS 5Y-12.41%
EPS Q2Q%0%
EPS Next Y10.62%
EPS Next 2Y12.22%
EPS Next 3Y10.85%
EPS Next 5YN/A
Revenue 1Y (TTM)-20.38%
Revenue growth 3Y-4.17%
Revenue growth 5Y7.73%
Sales Q2Q%7.85%
Revenue Next Year5.57%
Revenue Next 2Y5.41%
Revenue Next 3Y6.69%
Revenue Next 5YN/A
EBIT growth 1Y-11.94%
EBIT growth 3Y0.76%
EBIT growth 5Y6.49%
EBIT Next Year124.09%
EBIT Next 3Y37.63%
EBIT Next 5YN/A
FCF growth 1Y54.36%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y23.23%
OCF growth 3Y-1.39%
OCF growth 5Y3.28%

ALGONQUIN PWR & UTILITY - AQNCN 8.86372 07/01/2079 / AQNB Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for ALGONQUIN PWR & UTILITY - AQNCN 8.86372 07/01/2079?

ChartMill assigns a fundamental rating of 3 / 10 to AQNB.


What is the valuation status of ALGONQUIN PWR & UTILITY - AQNCN 8.86372 07/01/2079 (AQNB) stock?

ChartMill assigns a valuation rating of 0 / 10 to ALGONQUIN PWR & UTILITY - AQNCN 8.86372 07/01/2079 (AQNB). This can be considered as Overvalued.


Can you provide the profitability details for ALGONQUIN PWR & UTILITY - AQNCN 8.86372 07/01/2079?

ALGONQUIN PWR & UTILITY - AQNCN 8.86372 07/01/2079 (AQNB) has a profitability rating of 4 / 10.


How financially healthy is ALGONQUIN PWR & UTILITY - AQNCN 8.86372 07/01/2079?

The financial health rating of ALGONQUIN PWR & UTILITY - AQNCN 8.86372 07/01/2079 (AQNB) is 3 / 10.


What is the expected EPS growth for ALGONQUIN PWR & UTILITY - AQNCN 8.86372 07/01/2079 (AQNB) stock?

The Earnings per Share (EPS) of ALGONQUIN PWR & UTILITY - AQNCN 8.86372 07/01/2079 (AQNB) is expected to grow by 10.62% in the next year.